Diversity-Oriented Enzymatic Synthesis of Cyclopropane Building Blocks

Bruce J. Wittmann, Anders M. Knight, Julie L. Hofstra, Sarah E. Reisman, S. B. Jennifer Kan, Frances H. ArnoldACS 2020 · DOI

Abstract

While biocatalysis is increasingly incorporated into drug development pipelines, it is less commonly used in the early stages of drug discovery. By engineering a protein to produce a chiral motif with a derivatizable functional handle, biocatalysts can be used to help generate diverse building blocks for drug discovery. Here we show the engineering of two variants of <i>Rhodothermus marinus</i> nitric oxide dioxygenase (<i>Rma</i>NOD) to catalyze the formation of <i>cis</i>- and <i>tran-</i> diastereomers of a pinacolboronate-substituted cyclopropane which can be readily derivatized to generate diverse stereopure cyclopropane building blocks.
BibTeX
@inproceedings{wittmann2020diversity,
  author = {Bruce J. Wittmann and Anders M. Knight and Julie L. Hofstra and Sarah E. Reisman and S. B. Jennifer Kan and Frances H. Arnold},
  title = {{Diversity-Oriented Enzymatic Synthesis of Cyclopropane Building Blocks}},
  booktitle = {ACS},
  year = {2020},
  doi = {10.1021/acscatal.0c01888},
}

Loading related content...

Figure